Although the vast majority of patients with a large-bowel primary have tumors amenable to curative resection at the time of diagnosis, the disease recurs in more than half of the patients, with the liver involved in up to two-thirds of the cases. Synchronous liver metastases are diagnosed in approximately 15% of the cases. In such patients, liver disease represents the sole site of distant metastases in more than 75%. Metachronous liver metastases develop in 16–20% of patients usually within the first 3 years. Untreated liver metastases have a grim prognosis. Liver resection is the only potentially curative treatment although only 20% of patients can be considered as candidates for surgery.


Colorectal Cancer Rectal Cancer Liver Metastasis Hepatic Resection Hepatic Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMedGoogle Scholar
  2. 2.
    Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRefPubMedGoogle Scholar
  3. 3.
    Italian cancer trends (1998–2005). Report 2009. Available at http://www.registritumori. it/PDF/AIRTUM2009Trend/E&P33_4-5S1_38_colonretto.pdf. Accessed May, 15th, 2010Google Scholar
  4. 4.
    Manfredi S, Lepage C, Hatem C et al (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259CrossRefPubMedGoogle Scholar
  5. 5.
    Manfredi S, Bouvier AM, Lepage C et al (2006) Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 93:1115–1122CrossRefPubMedGoogle Scholar
  6. 6.
    Leporrier J, Maurel J, Chiche L et al (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRefPubMedGoogle Scholar
  7. 7.
    Gatta G, Capocaccia R, Sant M et al (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47:533–538CrossRefPubMedGoogle Scholar
  8. 8.
    Phelip JM, Grosclaude P, Launoy G (2005) Are there regional differences in the management of colon cancer in France? Eur J Cancer 131:504–510Google Scholar
  9. 9.
    Kune GA, Kune S, Field B et al (1990) Survival in patients with large-bowel cancer: a population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 33:938–946CrossRefPubMedGoogle Scholar
  10. 10.
    Bengtsson G, Carlsson G, Hafstrom L et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589CrossRefPubMedGoogle Scholar
  11. 11.
    Norstein J, Silen W (1997) Natural history of liver metastases from colo-rectal carcinoma. J Gastrointest Surg 1:398–407CrossRefPubMedGoogle Scholar
  12. 12.
    Stangl R, Altendorf-Hofmann A, Charnley RM et al (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410CrossRefPubMedGoogle Scholar
  13. 13.
    Wagner JS, Adson MA, Adson MH et al (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–507CrossRefPubMedGoogle Scholar
  14. 14.
    Wood CB, Gillis CR, Blumgart LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288PubMedGoogle Scholar
  15. 15.
    Rougier P, Milan C, Lazorthes F et al (1995) Prospective study of prognostic factors in patients with unresected metastases from colorectal cancer. Br J Surg 82:1397–1400CrossRefPubMedGoogle Scholar
  16. 16.
    Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2011

Authors and Affiliations

  • Dario Ribero
    • 1
  1. 1.Division of Hepato-Bilio-Pancreatic and Digestive SurgeryMauriziano “Umberto I” HospitalTurinItaly

Personalised recommendations